296 related articles for article (PubMed ID: 31629006)
21. Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis.
Salomon RG
Ann N Y Acad Sci; 2005 Jun; 1043():327-42. PubMed ID: 16037255
[TBL] [Abstract][Full Text] [Related]
22. Identification of novel bioactive aldehyde-modified phosphatidylethanolamines formed by lipid peroxidation.
Guo L; Chen Z; Amarnath V; Davies SS
Free Radic Biol Med; 2012 Sep; 53(6):1226-38. PubMed ID: 22898174
[TBL] [Abstract][Full Text] [Related]
23. Aldehyde-sequestering drugs: tools for studying protein damage by lipid peroxidation products.
Burcham PC; Kaminskas LM; Fontaine FR; Petersen DR; Pyke SM
Toxicology; 2002 Dec; 181-182():229-36. PubMed ID: 12505316
[TBL] [Abstract][Full Text] [Related]
24. Protein adducts generated from products of lipid oxidation: focus on HNE and one.
Sayre LM; Lin D; Yuan Q; Zhu X; Tang X
Drug Metab Rev; 2006; 38(4):651-75. PubMed ID: 17145694
[TBL] [Abstract][Full Text] [Related]
25. Detection of 1,N2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal after gavage of trans-4-hydroxy-2-nonenal or induction of lipid peroxidation with carbon tetrachloride in F344 rats.
Wacker M; Wanek P; Eder E
Chem Biol Interact; 2001 Sep; 137(3):269-83. PubMed ID: 11566294
[TBL] [Abstract][Full Text] [Related]
26. Electrophilic reactive aldehydes as a therapeutic target in colorectal cancer prevention and treatment.
Gobert AP; Asim M; Smith TM; Williams KJ; Barry DP; Allaman MM; McNamara KM; Hawkins CV; Delgado AG; Zhao S; Piazuelo MB; Washington MK; Coburn LA; Rathmacher JA; Wilson KT
Oncogene; 2023 May; 42(20):1685-1691. PubMed ID: 37037901
[TBL] [Abstract][Full Text] [Related]
27. Oxidized phospholipids, isolevuglandins, and atherosclerosis.
Zhang W; Salomon RG
Mol Nutr Food Res; 2005 Nov; 49(11):1050-62. PubMed ID: 16270278
[TBL] [Abstract][Full Text] [Related]
28. Reaction Mechanism of Covalent Modification of Phosphatidylethanolamine Lipids by Reactive Aldehydes 4-Hydroxy-2-nonenal and 4-Oxo-2-nonenal.
Vazdar K; Vojta D; Margetić D; Vazdar M
Chem Res Toxicol; 2017 Mar; 30(3):840-850. PubMed ID: 28222263
[TBL] [Abstract][Full Text] [Related]
29. Interrelationship of lipid aldehydes (MDA, 4-HNE, and 4-ONE) mediated protein oxidation in muscle foods.
Huang Y; Sarkhel S; Roy A; Mohan A
Crit Rev Food Sci Nutr; 2023 Aug; ():1-17. PubMed ID: 37589270
[TBL] [Abstract][Full Text] [Related]
30. Congeners of N(alpha)-acetyl-L-cysteine but not aminoguanidine act as neuroprotectants from the lipid peroxidation product 4-hydroxy-2-nonenal.
Neely MD; Zimmerman L; Picklo MJ; Ou JJ; Morales CR; Montine KS; Amaranth V; Montine TJ
Free Radic Biol Med; 2000 Nov; 29(10):1028-36. PubMed ID: 11084291
[TBL] [Abstract][Full Text] [Related]
31. Isolevuglandin-type lipid aldehydes induce the inflammatory response of macrophages by modifying phosphatidylethanolamines and activating the receptor for advanced glycation endproducts.
Guo L; Chen Z; Amarnath V; Yancey PG; Van Lenten BJ; Savage JR; Fazio S; Linton MF; Davies SS
Antioxid Redox Signal; 2015 Jun; 22(18):1633-45. PubMed ID: 25751734
[TBL] [Abstract][Full Text] [Related]
32. Highly Reactive Isolevuglandins Promote Atrial Fibrillation Caused by Hypertension.
Prinsen JK; Kannankeril PJ; Sidorova TN; Yermalitskaya LV; Boutaud O; Zagol-Ikapitte I; Barnett JV; Murphy MB; Subati T; Stark JM; Christopher IL; Jafarian-Kerman SR; Saleh MA; Norlander AE; Loperena R; Atkinson JB; Fogo AB; Luther JM; Amarnath V; Davies SS; Kirabo A; Madhur MS; Harrison DG; Murray KT
JACC Basic Transl Sci; 2020 Jun; 5(6):602-615. PubMed ID: 32613146
[TBL] [Abstract][Full Text] [Related]
33. Lipid peroxidation and biogenic aldehydes: from the identification of 4-hydroxynonenal to further achievements in biopathology.
Comporti M
Free Radic Res; 1998 Jun; 28(6):623-35. PubMed ID: 9736314
[TBL] [Abstract][Full Text] [Related]
34. Oxidative modification of HDL by lipid aldehydes impacts HDL function.
Fadaei R; Davies SS
Arch Biochem Biophys; 2022 Nov; 730():109397. PubMed ID: 36116503
[TBL] [Abstract][Full Text] [Related]
35. New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts.
Roberts LJ; Salomon RG; Morrow JD; Brame CJ
FASEB J; 1999 Jul; 13(10):1157-68. PubMed ID: 10385607
[TBL] [Abstract][Full Text] [Related]
36. Covalent modifications of aminophospholipids by 4-hydroxynonenal.
Guichardant M; Taibi-Tronche P; Fay LB; Lagarde M
Free Radic Biol Med; 1998 Dec; 25(9):1049-56. PubMed ID: 9870558
[TBL] [Abstract][Full Text] [Related]
37. The Adductomics of Isolevuglandins: Oxidation of IsoLG Pyrrole Intermediates Generates Pyrrole⁻Pyrrole Crosslinks and Lactams.
Bi W; Jang GF; Zhang L; Crabb JW; Laird J; Linetsky M; Salomon RG
High Throughput; 2019 May; 8(2):. PubMed ID: 31083423
[TBL] [Abstract][Full Text] [Related]
38. Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal.
Doorn JA; Petersen DR
Chem Res Toxicol; 2002 Nov; 15(11):1445-50. PubMed ID: 12437335
[TBL] [Abstract][Full Text] [Related]
39. Pathophysiological relevance of aldehydic protein modifications.
Zarkovic N; Cipak A; Jaganjac M; Borovic S; Zarkovic K
J Proteomics; 2013 Oct; 92():239-47. PubMed ID: 23438936
[TBL] [Abstract][Full Text] [Related]
40. Isolevuglandin scavenger attenuates pressure overload-induced cardiac oxidative stress, cardiac hypertrophy, heart failure and lung remodeling.
Shang L; Weng X; Wang D; Yue W; Mernaugh R; Amarnath V; Weir EK; Dudley SC; Xu Y; Hou M; Chen Y
Free Radic Biol Med; 2019 Sep; 141():291-298. PubMed ID: 31254620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
